At the just completed BioProcess International Conference in Boston, a number of sessions focused on the Bioprocess 4.0 trend toward continuous bioprocessing operations. Akshat Mullerpatan, PhD, ...

Biopharma companies must weigh the operational complexity of continuous bioprocess against its potential productivity gains.

Continuous processing, already conventional in many manufacturing fields, has been establishing itself in biopharma, which is starting to realize continuous processing’s compelling advantages: ...

Eli Lilly’s breast cancer med Verzenio may look like your standard drug tablet—ovular, off-white, emblazoned with the dosage on the front and Lilly’s logo on the reverse—but behind that modest façade ...